Head of Product and Strategy
NLC Health Ventures
Head of Product and Strategy
NLC Health Ventures
Healthtech venture builder and accelerator
Location: Hamburg, Germany (with regular travel in Europe and to the US)
Reports to: Founders (Dr. Jury Schewel & Dr. Dimitry Schewel)
Compensation: Competitive salary + meaningful equity participation
ROB’E is an early-stage MedTech venture developing an AI-powered robotic platform for echocardiography. The technology aims to transform cardiac imaging and enable more precise, image-guided structural heart interventions.
The company was founded by Dr. Jury Schewel and Dr. Dimitry Schewel, both cardiologists and clinical leaders at Marienkrankenhaus Hamburg. ROB’E is part of the venture portfolio of NLC Health Ventures.
The company has already achieved key milestones, including:
ROB’E is now entering a critical phase of product development, clinical validation, and fundraising.
You combine strategic thinking with strong execution and are motivated to build a company.
Healthtech venture builder and accelerator
NLC Health Ventures is a European healthtech venture builder that finds, builds and scales health innovations by bringing together technology, entrepreneurs and capital to turn early-stage ideas from universities, research institutes and companies into ventures. It identifies promising technologies, recruits teams, provides development and funding, validates clinically, and guides products to market using internal funds and external partners. Its differentiators include a long-running European focus, a large in-house discovery pipeline screening over 1,500 technologies annually, and access to a network of 40+ healthcare experts and captive funds for hands-on venture development and clinical validation. The goal is to turn early-stage inventions into scaling health ventures that improve patient outcomes and create value for founders and investors.
Explore more opportunities at NLC Health Ventures